Thanks, Peter. Revenues from our Apex and Oxford Segments grew 9.4% year-over-year for the fourth quarter and 7.6% for the full year 2017. Both segments performed better than we expected coming into the quarter. Apex Systems, our largest division, continued to achieve growth rates above the market growth rate and led the performance of their segment, which Rand will discuss in a few minutes. Demand in the end markets we serve, IT, Creative/Digital/Marketing, Engineering and Life Sciences remains steady. Now onto the results of the Oxford segment, which is comprised of Oxford Core, CyberCoders, our permanent placement business, and Life Sciences Europe. Oxford Core and CyberCoders performed better than our expectations coming into the quarter, with Life Sciences Europe performing slightly better – slightly below initial expectations. For the fourth quarter of 2017, Oxford segment revenues were $144.4 million, down 0.3% year-over-year. Revenues decreased 3.5% for the segment on a sequential basis but increased 0.9% based on a same billable day basis. There were 2.7 fewer billable days in the fourth quarter of 2017 versus the third quarter of 2017. Segment revenues for the year were $588.8 million, down 2.5% over 2016. Oxford Core revenues, which account for 75% of the segment revenues, were down 3.2% year-over-year, but, as mentioned above, better than our initial forecast. The decline in revenue is attributable to the successful completion of a large project in the fourth quarter of last year, which had a $4.2 million impact on revenues. Despite the difficulty in growing over this significant project on a year-over-year basis, Oxford Core revenues grew 1.9% sequentially on an adjusted per billable day basis. We continue our hard work in this unit to improve growth rates and profitability levels. CyberCoders, our permanent placement service offering, which accounts for 95.7% of the segment’s permanent placement revenues, led segment growth up low-double digits year-over-year. CyberCoders momentum was positive throughout the quarter. Our Life Science offerings in Europe, the smallest contributor to total segment revenue, was up year-over-year low-single digits. Demand for our life sciences skill sets in the Benelux geographic markets remains strong. Gross margin for the segment was 41.8%, up 190 basis points year-over-year. Improvement in gross margin was primarily driven by a higher contribution of revenue from CyberCoders and improving pay to bill margin within the Oxford Core business. Based on the above, and better expense management within the Oxford Core unit specifically, the segment’s adjusted EBITDA results exceeded both our expectations and the prior year. Much of the hard work pointed at improving lost EBITDA margin at Oxford Core continues to show itself in the quarter’s results. I will now turn the call over to Rand Blazer. Rand?